Similarly, administration of a nanoparticle-based siRNA targeting SLC7A11 effectively suppressed tumor growth, reduced metastasis occurrence, inhibited activation of cancer-associated fibroblasts, and mitigated fibrosis in orthotopic pancreatic ductal adenocarcinoma tumors.111. This evidence concerns the gene SLC7A11 and pancreatic ductal adenocarcinoma.